Sorafenib Tosilate is a kinase inhibitor belonging to the multikinase inhibitor class, utilized in the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid cancer.… Read more










Sorafenib Tosilate is a kinase inhibitor belonging to the multikinase inhibitor class, utilized in the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid cancer. This therapeutic agent functions by inhibiting the VEGFR-2 and PDGFR-beta signaling pathways, effectively blocking tumor angiogenesis and cell proliferation. To support rigorous analytical requirements, laboratories utilize a comprehensive range of related compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled standards. These high-quality reference standards are essential for reliable impurity profiling, method validation, and consistent quality control of the active pharmaceutical ingredient. By providing consistent materials for structural characterization and quantification, these compounds assist in verifying the safety, potency, and compliance of drug products throughout the pharmaceutical development and manufacturing process.